Resetting the Stress System with a Mifepristone Challenge

Total Page:16

File Type:pdf, Size:1020Kb

Resetting the Stress System with a Mifepristone Challenge Cellular and Molecular Neurobiology https://doi.org/10.1007/s10571-018-0614-5 REVIEW PAPER Resetting the Stress System with a Mifepristone Challenge Sergiu Dalm1 · Adriaan M. Karssen1 · Onno C. Meijer1,2 · Joseph K. Belanoff3 · E. Ronald de Kloet1,2 Received: 15 July 2018 / Accepted: 18 August 2018 © The Author(s) 2018 Abstract Psychotic depression is characterized by elevated circulating cortisol, and high daily doses of the glucocorticoid/progesterone antagonist mifepristone for 1 week are required for significant improvement. Using a rodent model, we find that such high doses of mifepristone are needed because the antagonist is rapidly degraded and poorly penetrates the blood–brain barrier, but seems to facilitate the entry of cortisol. We also report that in male C57BL/6J mice, after a 7-day treatment with a high dose of mifepristone, basal blood corticosterone levels were similar to that of vehicle controls. This is surprising because after the first mifepristone challenge, corticosterone remained elevated for about 16 h, and then decreased towards vehicle control levels at 24 h. At that time, stress-induced corticosterone levels of the 1xMIF were sevenfold higher than the 7xMIF group, the latter response being twofold lower than controls. The 1xMIF mice showed behavioral hyperactivity during exploration of the circular hole board, while the 7xMIF mice rather engaged in serial search patterns. To explain this rapid reset of corticosterone secretion upon recurrent mifepristone administration, we suggest the following: (i) A rebound gluco- corticoid feedback after cessation of mifepristone treatment. (ii) Glucocorticoid agonism in transrepression and recruitment of cell-specific coregulator cocktails. (iii) A more prominent role of brain MR function in control of stress circuit activity. An overview table of neuroendocrine MIF effects is provided. The data are of interest for understanding the mechanistic underpinning of stress system reset as treatment strategy for stress-related diseases. Keywords Stress · Brain · Behavior · RU38486 · Glucocorticoid receptor · Mineralocorticoid receptor Introduction restores aberrant levels of the corticosteroids (Murphy et al. 1993; Belanoff et al. 2001, 2002; DeBattista and Belanoff Patients suffering from psychotic major depression benefit 2006; Flores et al. 2006; Blasey et al. 2009, 2011; Block from a brief treatment with the glucocorticoid/progester- et al. 2018), see for meta-analysis (Garner et al. 2016). The one receptor antagonist RU38486 or mifepristone (MIF), fast amelioration of psychotic and depressive symptoms is in a dose range of 600–1200 mg/day, once a day for four to thought to be at least in part due to restoration of glucocor- seven days. This high dose of the antiglucocorticoid rapidly ticoid action to which the untreated patient with psychotic improves emotional expressions and cognitive abilities, and depression is resistant, while the anti-progestin activity of MIF is not implicated (Belanoff et al. 2001; Thomson and Craighead 2008). A recent analysis of all controlled phase 2 Sergiu Dalm and Adriaan M. Karssen have contributed equally to and 3 studies (MIF: n = 833 and placebo: n = 627) suggested this work. that a dose of 1200 mg MIF/day for 7 days significantly * E. Ronald de Kloet reduced psychotic symptoms. For an effective treatment, cir- [email protected]; [email protected] culating plasma levels of ≥ 1637 ng MIF/ml blood appeared required, while under such conditions basal HPA-axis activ- 1 Division of Medical Pharmacology, Leiden/Amsterdam Center for Drug Research and Leiden University Medical ity was increased (Block et al. 2017, 2018). The data raise Center, Leiden University, P.O. Box 9502, 2300 RA Leiden, the question how MIF can exert this rapid effect on psychotic The Netherlands major depression. 2 Department of Medicine, Division of Endocrinology, Leiden In the current study, we will address this question from University Medical Center, Room C-7-44, Postal zone C7-Q, the perspective of adjustment in setpoint of stress system PO Box 9600, Leiden, The Netherlands activity by the antiglucocorticoid (Ratka et al. 1988; Hu 3 Corcept Therapeutics, Menlo Park, CA, USA Vol.:(0123456789)1 3 Cellular and Molecular Neurobiology et al. 2012). Previous studies have shown that the effect Fifth, continuous infusion of 100 ng MIF/hr i.c.v. for 3 of MIF on the HPA axis is dependent on the dose, route, days enhanced stress-induced corticosterone secretion and and daily frequency of administration. In addition, a more increased the circadian amplitude of basal corticosterone prominent role of the brain mineralocorticoid receptors level (Van Haarst et al. 1996; van Haarst et al. 1997). Con- (MRs) after blockade of GR is likely, while also extrahypo- tinuous i.c.v. infusion improved spatial memory, which was thalamic circuits are involved. Table 1 presents the published impaired, however, when MIF was administered daily as MIF effects on the HPA axis, which can be summarized as a bolus of 100 ng/rat i.c.v. immediate before or after the follows. learning trial (Oitzl and de Kloet 1992; Oitzl et al. 1998). First, a central action of MIF is likely, since more than The findings reinforce the notion of temporal and contextual 100,000-fold lower dose centrally (10–100 ng local and diversity in glucocorticoid actions in various brain regions i.c.v.) than systemically (10–200 mg s.c. /kg rat) could (Joëls and de Kloet 1992; Joëls et al. 2018). achieve feedback blockade in behaviorally active fashion Finally, twice rather than once a day MIF enhanced (de Kloet et al. 1988; Ratka et al. 1989; van Haarst et al. HPA-axis activity in diabetic rats (Revsin et al. 2009; Stra- 1997; Dalm et al. 2008). In spite of rapid degradation and nahan et al. 2008) and, if applied at the end of three weeks poor brain penetration, such doses of MIF in the 10–200 mg daily stress exposure, blocked the reduction in neurogen- range can enter the brain and do translocate the immunoreac- esis (Oomen et al. 2007; Mayer et al. 2006); even a single tive (ir) glucocorticoid receptor (GR) to the neuronal nuclei day treatment on day 18 was effective in this paradigm (Hu (Van Eekelen et al. 1987; de Kloet 1991). This finding was et al. 2012). MIF administered twice a day, at postnatal days confirmed and further extended by the association of the 26–28, normalized deficits in hippocampal-dependent cog- MIF–GR complex to hippocampal Glucocorticoid Response nitive functions and associated neuronal activity that were Elements (GRE’s) (Spiga et al. 2011). 3H-MIF was found to previously induced by early-life maternal deprivation of rats bind to glucocorticoid receptor sites in human brain slices (Arp et al. 2016; Loi et al. 2017). in vitro (Sarrieau et al. 1986). A striking aspect of MIF’s efficacy is the ability to Second, the prolonged and profound increase in secretion reset the stress system. This phenomenon was previously of corticosterone was the expected outcome of MIF interfer- observed when the adrenals were rapidly (within 30 s under ence with the stress-induced GR-mediated negative feedback anesthesia) removed immediately following a severe stress (Ratka et al. 1989). The low GR occupancy during basal to prevent the surge in glucocorticoid secretion. We noted a trough conditions explains the lack of acute MIF effects, long-lasting (> 1 week) and profound potentiation in mor- but the antagonist can block during the p.m. phase or after phine- or β-endorphin-induced analgesia, which was corre- minor stressors provided corticosterone levels are increased lated with increased opioid receptor binding and decreased (Reul and de Kloet 1985). hippocampal enkephalin and dynorphin mRNA expression. Third, following MIF, the initial stress-induced rise in The antinociceptive effect of morphine was normalized if HPA-axis activity was attenuated. This blunted HPA-axis corticosterone was administered at the time of adrenalec- response likely was due to activation of co-localized hip- tomy (ADX) to mimic the stress or circadian rise. Also, pocampal MRs. These MRs mediate rapid actions of corti- 100 ng MIF i.c.v. administered during the p.m. circadian costerone that precede those of GRs (de Kloet 1991; Joëls rise at 1 h prior to ADX caused long-term sensitization to and de Kloet 1992; Karst et al. 2005; Joëls 2006). Indeed, morphine, apparently because the impact of the high pre- central (hippocampal) MR blockade disinhibited the HPA- stress corticosterone in brain was antagonized (Ratka et al. axis activity in rodents (Ratka et al. 1989; Oitzl et al. 1995; 1988; Iglesias et al. 1991). van Haarst et al. 1997) and humans (Dodt et al. 1993; Young In the present study, we mimicked in mice the high-dose et al. 1998; Deuschle et al. 1998). regimen of MIF that was beneficial in the patient studies Fourth, repeated daily administration for 5 days up to (Block et al. 2018). For this purpose, we applied a non- three weeks revealed an unexpected apparent GR agonism of invasive stress-free method for steroid delivery via oats MIF and blocked basal and stress-induced HPA-axis activ- (Dalm et al. 2008). After the first (1xMIF) and the seventh ity in rodents (Havel et al. 1996; Wulsin et al. 2010; van der administration (7xMIF) we assessed (i) the circadian corti- Veen et al. 2013). Similar GR agonism rather than antag- costerone secretion pattern; (ii) the behavioral and corticos- onism was noted with the novel selective GR modulators terone response to novelty during exploration of a circular C-108297, C-125281, and the GR modulator/MR antagonist hole board at 24 h post-treatment. Hippocampal and hypo- C-118335 (Solomon et al. 2014; Nguyen et al. 2017; Kroon thalamic MR, GR, and CRH mRNA expressions were also et al. 2018; Van den Heuvel et al. 2016). Repeated MIF treat- measured.
Recommended publications
  • Glucocorticoid Receptor Blockade Normalizes Hippocampal Alterations and Cognitive Impairment in Streptozotocin- Induced Type 1 Diabetes Mice
    Neuropsychopharmacology (2009) 34, 747–758 & 2009 Nature Publishing Group All rights reserved 0893-133X/09 $32.00 www.neuropsychopharmacology.org Glucocorticoid Receptor Blockade Normalizes Hippocampal Alterations and Cognitive Impairment in Streptozotocin- Induced Type 1 Diabetes Mice ,1,2 1 1 2 2 Yanina Revsin* , Niels V Rekers , Mieke C Louwe , Flavia E Saravia , Alejandro F De Nicola , 1 1 E Ron de Kloet and Melly S Oitzl 1 Division of Medical Pharmacology, Leiden/Amsterdam Center for Drug Research, Leiden University Medical Center, Leiden, The Netherlands; 2 Laboratory of Neuroendocrine Biochemistry, IBYME, Buenos Aires, Argentina Type 1 diabetes is a common metabolic disorder accompanied by an increased secretion of glucocorticoids and cognitive deficits. Chronic excess of glucocorticoids per se can evoke similar neuropathological signals linked to its major target in the brain, the hippocampus. This deleterious action exerted by excess adrenal stress hormone is mediated by glucocorticoid receptors (GRs). The aim of the present study was to assess whether excessive stimulation of GR is causal to compromised neuronal viability and cognitive performance associated with the hippocampal function of the diabetic mice. For this purpose, mice had type 1 diabetes induced by streptozotocin (STZ) administration (170 mg/kg, i.p.). After 11 days, these STZ-diabetic mice showed increased glucocorticoid secretion and hippocampal alterations characterized by: (1) increased glial fibrillary acidic protein-positive astrocytes as a marker reacting to neurodegeneration, (2) increased c-Jun expression marking neuronal activation, (3) reduced Ki-67 immunostaining indicating decreased cell proliferation. At the same time, mild cognitive deficits became obvious in the novel object-placement recognition task.
    [Show full text]
  • Salivary 17 Α-Hydroxyprogesterone Enzyme Immunoassay Kit
    SALIVARY 17 α-HYDROXYPROGESTERONE ENZYME IMMUNOASSAY KIT For Research Use Only Not for use in Diagnostic Procedures Item No. 1-2602, (Single) 96-Well Kit; 1-2602-5, (5-Pack) 480 Wells Page | 1 TABLE OF CONTENTS Intended Use ................................................................................................. 3 Introduction ................................................................................................... 3 Test Principle ................................................................................................. 4 Safety Precautions ......................................................................................... 4 General Kit Use Advice .................................................................................... 5 Storage ......................................................................................................... 5 pH Indicator .................................................................................................. 5 Specimen Collection ....................................................................................... 6 Sample Handling and Preparation ................................................................... 6 Materials Supplied with Single Kit .................................................................... 7 Materials Needed But Not Supplied .................................................................. 8 Reagent Preparation ....................................................................................... 9 Procedure ...................................................................................................
    [Show full text]
  • Agonistic and Antagonistic Properties of Progesterone Metabolites at The
    European Journal of Endocrinology (2002) 146 789–800 ISSN 0804-4643 EXPERIMENTAL STUDY Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor M Quinkler, B Meyer, C Bumke-Vogt, C Grossmann, U Gruber, W Oelkers, S Diederich and V Ba¨hr Department of Endocrinology, Klinikum Benjamin Franklin, Freie Universita¨t Berlin, Hindenburgdamm 30, 12200 Berlin, Germany (Correspondence should be addressed to M Quinkler; Email: [email protected]) Abstract Objective: Progesterone binds to the human mineralocorticoid receptor (hMR) with nearly the same affinity as do aldosterone and cortisol, but confers only low agonistic activity. It is still unclear how aldosterone can act as a mineralocorticoid in situations with high progesterone concentrations, e.g. pregnancy. One mechanism could be conversion of progesterone to inactive compounds in hMR target tissues. Design: We analyzed the agonist and antagonist activities of 16 progesterone metabolites by their binding characteristics for hMR as well as functional studies assessing transactivation. Methods: We studied binding affinity using hMR expressed in a T7-coupled rabbit reticulocyte lysate system. We used co-transfection of an hMR expression vector together with a luciferase reporter gene in CV-1 cells to investigate agonistic and antagonistic properties. Results: Progesterone and 11b-OH-progesterone (11b-OH-P) showed a slightly higher binding affinity than cortisol, deoxycorticosterone and aldosterone. 20a-dihydro(DH)-P, 5a-DH-P and 17a-OH-P had a 3- to 10-fold lower binding potency. All other progesterone metabolites showed a weak affinity for hMR. 20a-DH-P exhibited the strongest agonistic potency among the metabolites tested, reaching 11.5% of aldosterone transactivation.
    [Show full text]
  • Regulation of Intestinal Inflammation by Soybean and Soy-Derived Compounds
    foods Review Regulation of Intestinal Inflammation by Soybean and Soy-Derived Compounds Abigail Raffner Basson 1,2,* , Saleh Ahmed 2, Rawan Almutairi 3, Brian Seo 2 and Fabio Cominelli 1,2 1 Division of Gastroenterology & Liver Diseases, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA; [email protected] 2 Digestive Health Research Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA; [email protected] (S.A.); [email protected] (B.S.) 3 Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA; [email protected] * Correspondence: [email protected] Abstract: Environmental factors, particularly diet, are considered central to the pathogenesis of the inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis. In particular, the Westernization of diet, characterized by high intake of animal protein, saturated fat, and refined carbohydrates, has been shown to contribute to the development and progression of IBD. During the last decade, soybean, as well as soy-derived bioactive compounds (e.g., isoflavones, phytosterols, Bowman-Birk inhibitors) have been increasingly investigated because of their anti-inflammatory properties in animal models of IBD. Herein we provide a scoping review of the most studied disease mechanisms associated with disease induction and progression in IBD rodent models after feeding of either the whole food or a bioactive present in soybean. Keywords: inflammatory bowel disease; isoflavone; bioactive compound; isoflavones; inflammation; Crohn’s disease; western diet; plant-based Citation: Basson, A.R.; Ahmed, S.; Almutairi, R.; Seo, B.; Cominelli, F. Regulation of Intestinal Inflammation by Soybean and Soy-Derived Compounds. Foods 2021, 10, 774.
    [Show full text]
  • Quantification of Hair Corticosterone, DHEA and Testosterone As
    animals Article Quantification of Hair Corticosterone, DHEA and Testosterone as a Potential Tool for Welfare Assessment in Male Laboratory Mice Alberto Elmi 1 , Viola Galligioni 2, Nadia Govoni 1 , Martina Bertocchi 1 , Camilla Aniballi 1 , Maria Laura Bacci 1 , José M. Sánchez-Morgado 2 and Domenico Ventrella 1,* 1 Department of Veterinary Medical Sciences, University of Bologna, 40064 Ozzano dell’Emilia, BO, Italy; [email protected] (A.E.); [email protected] (N.G.); [email protected] (M.B.); [email protected] (C.A.); [email protected] (M.L.B.) 2 Comparative Medicine Unit, Trinity College Dublin, D02 Dublin, Ireland; [email protected] (V.G.); [email protected] (J.M.S.-M.) * Correspondence: [email protected]; Tel.: +39-051-2097-926 Received: 11 November 2020; Accepted: 14 December 2020; Published: 16 December 2020 Simple Summary: Mice is the most used species in the biomedical research laboratory setting. Scientists are constantly striving to find new tools to assess their welfare, in order to ameliorate husbandry conditions, leading to a better life and scientific data. Steroid hormones can provide information regarding different behavioral tracts of laboratory animals but their quantification often require stressful sampling procedures. Hair represents a good, less invasive, alternative in such scenario and is also indicative of longer timespan due to hormones’ accumulation. The aim of the work was to quantify steroid hormones in the hair of male laboratory mice and to look for differences imputable to age and housing conditions (pairs VS groups). Age influenced all analysed hormones by increasing testosterone and dehydroepiandrosterone (DHEA) levels and decreasing corticosterone.
    [Show full text]
  • The Effects of Dehydroepiandrosterone Sulfate on Counterregulatory Responses During Repeated Hypoglycemia in Conscious Normal Rats Darleen A
    The Effects of Dehydroepiandrosterone Sulfate on Counterregulatory Responses During Repeated Hypoglycemia in Conscious Normal Rats Darleen A. Sandoval, Ling Ping, Ray Anthony Neill, Sachiko Morrey, and Stephen N. Davis ␮ ⅐ ؊1 ⅐ ؊1 We previously determined that both antecedent hy- mol/l kg min ; P < 0.05). In summary, day-1 poglycemia and elevated cortisol levels blunt neu- antecedent hypoglycemia blunted neuroendocrine and roendocrine and metabolic responses to subsequent metabolic responses to next-day hypoglycemia. How- hypoglycemia in conscious, unrestrained rats. The adre- ever, simultaneous DHEA-S infusion during antecedent nal steroid dehydroepiandrosterone sulfate (DHEA-S) hypoglycemia preserved neuroendocrine and metabolic has been shown in several studies to oppose corticoste- counterregulatory responses during subsequent hypo- roid action. The purpose of this study was to determine glycemia in conscious rats. Diabetes 53:679–686, 2004 if DHEA-S could preserve counterregulatory responses during repeated hypoglycemia. We studied 40 male Sprague-Dawley rats during a series of 2-day protocols. he Diabetes Control and Complications Trial Day 1 consisted of two 2-h episodes of 1) hyperinsuline- mic (30 pmol ⅐ kg؊1 ⅐ min؊1) euglycemia (6.2 ؎ 0.2 established that intensive glucose control in type ANTE EUG), 2) hyperinsulinemic eug- 1 diabetic patients can slow the progression or ;12 ؍ mmol/l; n -plus simultaneous Tsignificantly reduce the onset of diabetic micro (8 ؍ lycemia (6.0 ؎ 0.1 mmol/l; n intravenous infusion of DHEA-S (30 mg/kg; ANTE EUG vascular complications (e.g., retinopathy, nephropathy, ؉ DHEA-S), 3) hyperinsulinemic hypoglycemia (2.8 ؎ neuropathy) (1). Unfortunately, the study also established ANTE HYPO), or 4) hyperinsulinemic that intensive glucose treatment causes an approximate ;12 ؍ mmol/l; n 0.1 -with simulta- threefold increase in the frequency of severe hypoglyce (8 ؍ hypoglycemia (2.8 ؎ 0.1 mmol/l; n neous intravenous infusion of DHEA-S (30 mg/kg; ANTE mia (2).
    [Show full text]
  • Plasma Corticosterone Levels in the Male Iguanid Lizard, Sceloporus Cyanogenys, Under Various Physiological Conditions
    W&M ScholarWorks Dissertations, Theses, and Masters Projects Theses, Dissertations, & Master Projects 1971 Plasma Corticosterone Levels in the Male Iguanid Lizard, Sceloporus cyanogenys, Under Various Physiological Conditions David Reams Daugherty College of William & Mary - Arts & Sciences Follow this and additional works at: https://scholarworks.wm.edu/etd Part of the Physiology Commons Recommended Citation Daugherty, David Reams, "Plasma Corticosterone Levels in the Male Iguanid Lizard, Sceloporus cyanogenys, Under Various Physiological Conditions" (1971). Dissertations, Theses, and Masters Projects. Paper 1539624722. https://dx.doi.org/doi:10.21220/s2-jk2d-cq40 This Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M ScholarWorks. It has been accepted for inclusion in Dissertations, Theses, and Masters Projects by an authorized administrator of W&M ScholarWorks. For more information, please contact [email protected]. PLASMA CORTICOSTERONE LEVELS IN THE MALE IGUANID LIZARD, SCELOPORUS CYANOGENYS, UNDER VARIOUS PHYSIOLOGICAL CONDITIONS A Thesis Presented to The Faculty of the Department of Biology The College of William and Mary in Virginia In Partial Fulfillment Of the Requirements for the Degree of Master of Arts By David Reams Daugherty 1971 APPROVAL SHEET This thesis is submitted in partial fulfillment of the requirements for the degree of Master of Arts UT Author Approved , May 1971 Callard, Ph. D f - Robert E. L. Black, Ph. D. Jafid A. Simons, Ph. D ii S~0 4i04 -G«.~ : J lu ) ■ ACKNOWLEDGMENTS The writer wishes to express his appreciation to Professor Ian P. Callard, under whose direction this invest­ igation was conducted, for his preparation of the hypophy- sectomized and lesioned groups, and for his patient guidance and criticism throughout the investigation.
    [Show full text]
  • Progesterone Using ALZET Osmotic Pumps
    ALZET® Bibliography References on the Administration of Progesterone Using ALZET Osmotic Pumps Q8558: V. Joseph, et al. Progesterone decreases apnoea and reduces oxidative stress induced by chronic intermittent hypoxia in ovariectomized female rats. Exp Physiol 2020;105(6):1025-1034 Agents: Progesterone Vehicle: Cyclodextrin, 2-ß-Hydroxypropl-; Route: SC; Species: Rat; Pump: 2ML4; Duration: 28 days; ALZET Comments: Dose (4 mg/kg/day); Controls received mp w/ vehicle; animal info (Sprague-Dawley female rats (220-250g/57-70 days old)); post op. care (buprenorphine); Blood pressure measured via tail cuff method;93.3 mmHg - 105.2 mmHg;Progesterone aka prog; dependence; Q6232: S. F. Rosen, et al. T-Cell Mediation of Pregnancy Analgesia Affecting Chronic Pain in Mice. J Neurosci 2017;37(41):9819-9827 ALZET Comments: Estradiol, 17b-; Progesterone sulfate; SC; Mice; 2002; 14 days; Dose (17b-estradiol : 0.1 mg/kg/d, progesterone sulfate: 0.25 mg/kg/d, 0.1 mg/kg/d estradiol + 0.25 mg/kg/d progesterone); Controls received mp w/ vehicle; animal info (7-12 week old female C57BL/6J mice); replacement therapy (estradiol, ovariectomy); Therapeutic indication. Q6066: D. J. Morris, et al. Glucocorticoids and gut bacteria: "The GALF Hypothesis" in the metagenomic era. Steroids 2017;125(1-13 ALZET Comments: Chenodeoxycholic acid, progesterone, 11b-hydroxy-, corticosterone, deoxy-, corticosterone, 3α,5α-TH-, progesterone, 3α,5α-TH-11β-hydroxy-; SC; Rat; steroidal derivatives of corticosterone; Review presents the role of gut microbial metabolism of endogenous adrenocorticosteroids as a contributing factor in the etiology of essential hypertension. Q6204: S. McIlvride, et al. A progesterone-brown fat axis is involved in regulating fetal growth.
    [Show full text]
  • Mifepristone in the Central Nucleus of the Amygdala Reduces Yohimbine Stress-Induced Reinstatement of Ethanol-Seeking
    Neuropsychopharmacology (2012) 37, 906–918 & 2012 American College of Neuropsychopharmacology. All rights reserved 0893-133X/12 www.neuropsychopharmacology.org Mifepristone in the Central Nucleus of the Amygdala Reduces Yohimbine Stress-Induced Reinstatement of Ethanol-Seeking 1 1,2 1 1 ,1 Jeffrey A Simms , Carolina L Haass-Koffler , Jade Bito-Onon , Rui Li and Selena E Bartlett* 1 Preclinical Development Group, Ernest Gallo Clinic and Research Center at University of California San Francisco, Emeryville, CA, USA; 2 Clinical Pharmacology and Experimental Therapeutics, University of California San Francisco, Byers Hall, San Francisco, CA, USA Chronic ethanol exposure leads to dysregulation of the hypothalamic-pituitary-adrenal axis, leading to changes in glucocorticoid release and function that have been proposed to maintain pathological alcohol consumption and increase vulnerability to relapse during abstinence. The objective of this study was to determine whether mifepristone, a glucocorticoid receptor antagonist, plays a role in ethanol self-administration and reinstatement. Male, Long–Evans rats were trained to self-administer either ethanol or sucrose in daily 30 min operant self-administration sessions using a fixed ratio 3 schedule of reinforcement. Following establishment of stable baseline responding, we examined the effects of mifepristone on maintained responding and yohimbine-induced increases in responding for ethanol and sucrose. Lever responding was extinguished in separate groups of rats and animals were tested for yohimbine-induced reinstatement and corticosterone release. We also investigated the effects of local mifepristone infusions into the central amygdala (CeA) on yohimbine-induced reinstatement of ethanol- and sucrose-seeking. In addition, we infused mifepristone into the basolateral amygdala (BLA) in ethanol-seeking animals as an anatomical control.
    [Show full text]
  • REVIEW Rapid Non-Genomic Effects of Corticosteroids and Their Role in The
    153 REVIEW Rapid non-genomic effects of corticosteroids and their role in the central stress response Femke L Groeneweg, Henk Karst1, E Ron de Kloet and Marian Joe¨ls1 Department of Medical Pharmacology, Leiden Amsterdam Center for Drug Research and Leiden University Medical Center, Leiden University, Einsteinweg 55, 2333CC Leiden, The Netherlands 1Department of Neuroscience and Pharmacology, University Medical Center Utrecht, Universiteitsweg 100, 3584CG Utrecht, The Netherlands (Correspondence should be addressed to F L Groeneweg; Email: fl[email protected]) Abstract In response to a stressful encounter, the brain activates a neuroendocrine output within minutes. Knowledge on the comprehensive stress system that engages the organism in an identity of the receptors and secondary pathways mediating adaptive response to the threatening situation. This stress the non-genomic effects of corticosteroids on a cellular level system acts on multiple peripheral tissues and feeds back to the is accumulating. Interestingly, in many cases, an essential role brain; one of its key players is the family of corticosteroid for the ‘classical’ mineralocorticoid and glucocorticoid hormones. Corticosteroids affect brain functioning through receptors in a novel membrane-associated mechanism is both delayed, genomic and rapid, non-genomic mechanisms. found. Here, we systematically review the recent literature on The latter mode of action has long been known, but it is only non-genomic actions of corticosteroids on neuronal activity in recent years that the physiological basis in the brain is and functioning in selected limbic brain targets. Further, we beginning to be unravelled. We now know that corticoster- discuss the relevance of these permissive effects for cognition oids exert rapid, non-genomic effects on the excitability and and neuroendocrine control, and the integration of this novel activation of neurons in (amongst others) the hypothalamus, mode of action into the complex balanced pattern of stress hippocampus, amygdala and prefrontal cortex.
    [Show full text]
  • Corticosterone Using ALZET Osmotic Pumps
    ALZET® Bibliography References on the Administration of Corticosterone Using ALZET Osmotic Pumps Q8365: R. J. Perry, et al. Leptin's hunger-suppressing effects are mediated by the hypothalamic-pituitary-adrenocortical axis in rodents. Proc Natl Acad Sci U S A 2019;116(27):13670-13679 Agents: Corticosterone Vehicle: Saline; Route: CNS/CSF; Species: Mice; Pump: Not stated; Duration: 14 days; ALZET Comments: Dose (0.75 mg/d or 2.0 mg/d); 0.9% Saline used; animal info (8-12 weeks old, C57BL/6); diabetes; Q8070: Y. S. Lee, et al. Infrequent Feeding of Restricted Amounts of Food Induces Stress and Adipose Tissue Inflammation, Contributing to Impaired Glucose Metabolism. Int J Med Sci 2018;15(14):1667-1675 Agents: Corticosterone Vehicle: Saline; Route: SC; Species: Mice; Pump: 1003D; Duration: 3 days; ALZET Comments: Dose (15 ug/hr); Controls received mp w/ vehicle; animal info (Male, C57BL/6); dependence; Q6066: D. J. Morris, et al. Glucocorticoids and gut bacteria: "The GALF Hypothesis" in the metagenomic era. Steroids 2017;125(1-13 Agents: Chenodeoxycholic acid, progesterone, 11b-hydroxy-, corticosterone, deoxy-, corticosterone, 3α,5α-TH-, progesterone, 3α,5α-TH-11β-hydroxy- Vehicle: Not Stated; Route: SC; Species: Rat; Pump: Not Stated; Duration: Not Stated; ALZET Comments: steroidal derivatives of corticosterone; Review presents the role of gut microbial metabolism of endogenous adrenocorticosteroids as a contributing factor in the etiology of essential hypertension. Q6077: D. E. Livingstone, et al. Metabolic dysfunction in female mice with disruption of 5alpha-reductase 1. J Endocrinol 2017;232(1):29-36 Agents: Corticosterone Vehicle: DMSO; Propylene glycol; Route: Not Stated; Species: Mice; Pump: Not Stated; Duration: Not Stated; ALZET Comments: Dose (100 ug/day); 50% DMSO, 50% Propylene glycol used; animal info (Female 3-4 month old 5αR1-KO and wild-type mice); replacement therapy (glucocorticoid); Q6029: A.
    [Show full text]
  • Rat Prostatic Weight Regression in Reaction to Ketoconazole
    [CANCER RESEARCH 48, 6063-6068, November 1, 1988] Rat Prostatic Weight Regression in Reaction to Ketoconazole, Cyproterone Acetate, and RU 23908 as Adjuncts to a Depot Formulation of Gonadotropin-releasing Hormone Analogue Steven W. J. Lamberts,1 Piet Uitterlinden, and Frank H. de Jong Department of Medicine, Erasmus University, Rotterdam, The Netherlands ABSTRACT The effects of the s.c. administration of a depot formulation of the INTRODUCTION luteinizing hormone-releasing hormone (LHRH) analogue Zoladex were LHRH2 agonists initially stimulate pituitary gonadotropin studied in normal male rats, alone and in combination with three drugs with "antiandrogenic" action (ketoconazole, cyproterone acetate, and RU secretion resulting in an enhanced testosterone secretion, which 23908) on prostatic weight and on circulating hormone levels in order to is eventually followed by a depletion of pituitary LH stores and investigate whether these antiandrogens might prevent the LHRH-A- desensitization of LHRH receptors in the pituitary gland and of LH receptors in the gonads, and "medical" castration (1-4). induced initial increase in these parameters. These effects were compared with those caused by surgical castration. In addition the effects of the For these reasons treatment with LHRH-A results in inhibition antiandrogens on the activity of the hypothalamic-pituitary-adrenal axis of the growth of gonadal steroid-dependent tumors in humans were investigated. and animals (5-9). Several problems remain, however, with The depot LHRH analogue caused an initial increase in ventral pros regard to LHRH analogue treatment of male prostatic cancer tatic weight after 4 days but suppressed the prostatic and testicular patients: (a) the initial LHRH-induced increase in testosterone weights, the pituitary luteinizing hormone (1.11)content, and plasma LH secretion has been shown to cause a "flare-up" of the disease in and testosterone levels after 10 and 17 days.
    [Show full text]